NBP

Conviction 0HealthcareScan · Thu, Jun 25, 2026

NBP$1.61+0.63%

ResistanceSupportVol 14Insider buyInsider sell

Vol MA14 475.53K

Mar 26Apr 14May 1May 19Jun 8Jun 25

NovaBridge Bioscienceswww.novabridge.com ↗

Price1.61

Change+0.63%

Gap+0.63%

Rel volume0.80×

Avg volume490.7K

Avg $ vol794.16K

SMA 201.62

SMA 501.98

SMA 200—

Price vs 50-18.61%

Price vs 200—

MA stack—

50/200 cross—

Supertrenddown · 1.85

RSI (14)42

MACD hist0.03

MACD crossbull · 6d

Stoch %K / %D45 / 41

ADX (14)20

+DI / −DI18 / 18

RSI divergence—

MACD divergence—

ATR %+7.39%

ADR %7.20%

52w high4.95

52w low1.47

From 52w high-67.47%

Above 52w low+9.52%

New 52w highNo

SqueezeOff

Bollinger width29.72%

%B0.48

Donchian pos33.14%

Donchian high1.91

Donchian low1.46

AVWAP (52w high)2.76

vs AVWAP high-41.68%

AVWAP (52w low)1.54

vs AVWAP low+4.32%

OBV trendFlat

Chaikin MF (20)-0.23

Today vs 20d0.80×

Avg vol (14d)475.52K

Avg vol (20d)490.7K

Avg $ vol (20d)794.16K

Market cap427.26M

RS 3m (vs SPY)-48.76%

RS 6m (vs SPY)-69.55%

RS line new highNo

Trend template—

Technical rank14.8

1 week+2.55%

1 month-13.44%

3 months-39.02%

6 months-63.33%

1 year—

YTD-62.30%

P/E—

P/B1.85

P/S—

P/FCF—

EPS—

Div yield—

ROE—

ROA—

Debt/Eq0.02

Current8.09

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth—

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value220.85M

Revenue—

Net income—

Gross profit—

Free cash flow—

Industry—

ExchangeNasdaq

Shares out115.65M

Employees30

ListedFri, Jan 17, 2020

Free float—

Float %—

Short interest3.58M

Days to cover4.5d

Short volume53.1%

Squeeze score52 / 100

Next earningsThu, Jun 25, 2026 (0d)

EPS forecast−$0.12 · 1 est

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction0 / 100

Pattern quality—

Tech rank14.8 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance2.25

Support1.46

Days since event—

Candle confirm—

News sentiment—

Congress activity

Disclosed STOCK Act trades in NBP

All disclosures →

No recent disclosed trades by Congress in NBP. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in NBP · 5 buys · 5 sells

Insider	Side	Shares	Value	Traded	Filed
Cao Sean Wuxiong Chief Bus. Development Officer · 2025 Employee Share Option (right to buy) · 2026-06-22	Grant	181.29K	—	2026-06-22	2026-06-24
Cao Sean Wuxiong Chief Bus. Development Officer · Restricted Share Units · 2026-06-22	Grant	181.28K	—	2026-06-22	2026-06-24
Dennis Phillip Andrew Chief Medical Officer · Ordinary Shares · 2026-06-18	Sell	8.49K	$6K	2026-06-18	2026-06-22
Dennis Phillip Andrew Chief Medical Officer · Restricted Share Units · 2026-06-17	Exercise	10.3K	—	2026-06-17	2026-06-22
Dennis Phillip Andrew Chief Medical Officer · Ordinary Shares · 2026-06-17	Exercise	23.7K	—	2026-06-17	2026-06-22
Xu Cong Claire SVP, Clinical Development · Ordinary Shares · 2026-06-01	Sell	3.49K	$14K	2026-06-01	2026-06-02
Xu Cong Claire SVP, Clinical Development · Ordinary Shares · 2026-05-30	Exercise	9.38K	—	2026-05-30	2026-06-02
Xu Cong Claire SVP, Clinical Development · Restricted Share Units · 2026-05-30	Exercise	4.08K	$0	2026-05-30	2026-06-02
Cao Sean Wuxiong See Remarks · Ordinary Shares · 2026-05-14	Sell	21.4K	$43K	2026-05-14	2026-05-18
Hagler Mark Arnold See Remarks · Ordinary Shares · 2026-04-24	Buy	230K	$577K	2026-04-24	2026-04-28

SEC filings

EDGAR filings in NBP · 3 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.